Hira Nakhasi, PhD

U.S. Food and Drug Administration (USA)

Laia Solano-Gallego, PhD

Universitat Autònoma de Barcelona (Spain)

Christian Bogdan, PhD

University Hospital of Erlangen and Friedrich-Alexander-University (FAU) (Germany)

Jeronimo Carnes, PhD

Leti Pharma (Spain)

Hiro Goto, PhD

Department of Preventive Medicine, and Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo (Brazil)

Pleiotropic effects of insulin-like growth factor-I on Leishmania and leishmaniasis reveal species-related differences in immunometabolism

Pegine Walrad, PhD

York Biomedical Research Institute, York (UK)

Screening and modeling RNP trans-regulators of L.mexicana infectivity

Xavier Fernàndez Busquets, PhD

Institute for Bioengineering of Catalonia, Barcelona (Spain)

The protein aggregation dye YAT2150 is a potent antileishmanial agent